Showing results (981-990 of 1,055) with videos related to

Sort By:
Pageof 106
Redox Biology|July 24, 2025
15-Lipoxygenase-dependent radiomitigation by NO<sup>●</sup>-Donors suppresses ferroptosis in intestinal Epithelium: Multiomics MS imaging and LC-MS evidenceYulia Y Tyurina, Hua Tian, Haider H Dar, et al.
Molecular Cell|August 4, 2015
Interactions of Melanoma Cells with Distal Keratinocytes Trigger Metastasis via Notch Signaling Inhibition of MITFTamar Golan, Arielle R Messer, Aya Amitai-Lange, et al.
Cancers|March 29, 2023
Release of Interferon-β (IFN-β) from Probiotic <i>Limosilactobacillus reuteri</i>-IFN-β (LR-IFN-β) Mitigates Gastrointestinal Acute Radiation Syndrome (GI-ARS) following Whole Abdominal IrradiationDiala F Hamade, Michael W Epperly, Renee Fisher, et al.
Cancers|February 10, 2024
Genetically Engineered Probiotic <i>Limosilactobacillus reuteri</i> Releasing IL-22 (LR-IL-22) Modifies the Tumor Microenvironment, Enabling Irradiation in Ovarian CancerDiala F Hamade, Michael W Epperly, Renee Fisher, et al.
The World Allergy Organization Journal|November 18, 2020
World allergy organization anaphylaxis guidance 2020Victoria Cardona, Ignacio J Ansotegui, Motohiro Ebisawa, et al.
Journal of Medicinal Chemistry|September 1, 2000
4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitorsA Wissner, D M Berger, D H Boschelli, et al.
JAMA Oncology|July 9, 2017
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical TrialMohan Suntharalingam, Kathryn Winter, David Ilson, et al.
Molecular Pharmacology|November 3, 2007
Cellular and in vivo activity of JNJ-28871063, a nonquinazoline pan-ErbB kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial tumorsStuart L Emanuel, Terry V Hughes, Mary Adams, et al.
Lung Cancer (Amsterdam, Netherlands)|July 16, 2013
A multicenter phase II study of cetuximab in combination with chest radiotherapy and consolidation chemotherapy in patients with stage III non-small cell lung cancerS S Ramalingam, A Kotsakis, A A Tarhini, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 18, 2021
Food-induced anaphylaxis morbidity: Emergency department and hospitalization data support preventive strategiesLuciana Kase Tanno, Evangeline Clark, Myriam Mamodaly, et al.
Pageof 106